4.5 Review

Surgical oncology during the post-COVID-19 era: What is next?

Journal

JOURNAL OF SURGICAL ONCOLOGY
Volume 127, Issue 1, Pages 7-10

Publisher

WILEY
DOI: 10.1002/jso.27104

Keywords

cancer; COVID-19; multidisciplinary; surgical; treatment

Ask authors/readers for more resources

The management strategies for surgical oncology patients need to be reconsidered due to the impact of the COVID-19 pandemic on their survival and tumor progression rates.
During first outburst of COVID-19, several strategies had been applied for surgical oncology patients to minimize COVID-19 transmission. COVID-19 infection seemed to compromise survival and major complication rates of surgical oncology patients. However, survival, tumor progression and recurrence rates of surgical oncology patients were associated to the consequences of COVID-19 pandemic on their management. In addition, the severity of COVID-19 infections has been downgraded. Therefore, management of surgical oncology patients should be reconsidered.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available